Spironolactone (SP) is an aldosterone receptor blocker that is useful in preventing cardiovascular risk in patients with PA and resistant hypertension with normal aldosterone values [9]. This evidence concerns the gene NR3C2 and Hypertension resistant to conventional therapy.